Source: Translational Cancer Research. Unidade: ICB
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, INIBIDORES DE ENZIMAS, MUTAÇÃO GENÉTICA, ONCOGENES, CÉLULAS CULTIVADAS DE TUMOR, FÁRMACOS IMUNOSSUPRESSORES, MACRÓFAGOS, NEUTRÓFILOS, MONÓCITOS, CITOCINAS, MELANOMA
ABNT
ZHAO, Jing et al. FLT3 mutation-related immune checkpoint molecule absent in melanoma 2 (AIM2) contributes to immune infiltration in pediatric and adult acute myeloid leukemia: evidence from bioinformatics analysis. Translational Cancer Research, v. 13, n. 11, p. 6255–6272, 2024Tradução . . Disponível em: https://dx.doi.org/10.21037/tcr-24-1403. Acesso em: 07 out. 2025.APA
Zhao, J., Cui, Y., Zhou, D., Che, Z., Yun, Q., Damiani, D., et al. (2024). FLT3 mutation-related immune checkpoint molecule absent in melanoma 2 (AIM2) contributes to immune infiltration in pediatric and adult acute myeloid leukemia: evidence from bioinformatics analysis. Translational Cancer Research, 13( 11), 6255–6272. doi:10.21037/tcr-24-1403NLM
Zhao J, Cui Y, Zhou D, Che Z, Yun Q, Damiani D, Al-Kzayer L’a FY, Kulkarni R, Gu M, Machado Neto JA. FLT3 mutation-related immune checkpoint molecule absent in melanoma 2 (AIM2) contributes to immune infiltration in pediatric and adult acute myeloid leukemia: evidence from bioinformatics analysis [Internet]. Translational Cancer Research. 2024 ; 13( 11): 6255–6272.[citado 2025 out. 07 ] Available from: https://dx.doi.org/10.21037/tcr-24-1403Vancouver
Zhao J, Cui Y, Zhou D, Che Z, Yun Q, Damiani D, Al-Kzayer L’a FY, Kulkarni R, Gu M, Machado Neto JA. FLT3 mutation-related immune checkpoint molecule absent in melanoma 2 (AIM2) contributes to immune infiltration in pediatric and adult acute myeloid leukemia: evidence from bioinformatics analysis [Internet]. Translational Cancer Research. 2024 ; 13( 11): 6255–6272.[citado 2025 out. 07 ] Available from: https://dx.doi.org/10.21037/tcr-24-1403